Harmonizing Definitions for Diagnostic Criteria and Prognostic Assessment of Transplantation-Associated Thrombotic Microangiopathy: A Report on Behalf of the European Society for Blood and Marrow Transplantation, American Society for Transplantation and Cellular Therapy, Asia-Pacific Blood and Marrow Transplantation Group, and Center for International Blood and Marrow Transplant Research - Schoettler, M.L.; Carreras, E.; Cho, B.; Dandoy, C.E.; Ho, V.T.; Jodele, S.; Moissev, I.; Sanchez-Ortega, I.; Srivastava, A.; Atsuta, Y.; Carpenter, P.; Koreth, J.; et al. (Transplantation and cellular therapy, 2023)
Keywords: Bone Marrow; Child; Complement; Diagnostic criteria; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation - adverse effects; Humans; Nonrelapse mortality; Prognosis; Prospective Studies; Risk stratification; Thrombotic Microangiopathies - diagnosis; Thrombotic Microangiopathies - etiology; Thrombotic Microangiopathies - pathology; Transplantation-associated thrombotic microangiopathy; LDH; MOD; Diagnostic criteria; ULN; Risk stratification; Nonrelapse mortality; TA-TMA; Transplantation-associated thrombotic microangiopathy; Complement